SIH Partners’s Revolution Medicines RVMD Stock Holding History

SIH Partners’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,702	Closed	-$414K	–	282
2025 Q1	$414K	Buy	+11,702	New	+$475K	0.01%	174

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SIH Partners's RVMD Position: Q2 2025 in Review

SIH Partners sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 11,702 shares — an estimated $414K sold.

SIH Partners first reported a position in RVMD in Q1 2025 and held it in 1 quarter. The position peaked at $414K in Q1 2025. 307 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

SIH Partners reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 11,702 Revolution Medicines shares in Q2 2025, an estimated $414K.
SIH Partners first reported a position in Revolution Medicines in Q1 2025 and held it in 1 quarter.
SIH Partners's Revolution Medicines position peaked at $414K in Q1 2025.
307 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.